The PMPRB has released its CompassRx, 2017/18 Annual Public Drug Plan Expenditure Report and related news release reporting various statistics about prescription drug expenditures by Canadian public drug plans. The report indicates that prescription drug expenditures by public plans increased by 7.4% to $11.4 billion in 2017-18.
On August 14, 2019, the PMPRB announced the release of the latest edition of its Generics360 report, which reported that generic drugs prices have dropped significantly in recent years as a result of government initiatives and that the most recent agreement between the pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Alliance brought Canadian generic prices more closely in line with international prices.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.